000 | 01249nam a22001697a 4500 | ||
---|---|---|---|
008 | 211202b |||||||| |||| 00| 0 eng d | ||
020 | _a9780857112859 | ||
020 | _a 0857112856 | ||
110 |
_a Medicines & Healthcare Products Regulatory Agency _926003 |
||
245 | _aRules and Guidance for Pharmaceutical Manufacturers and Distributors (Orange Guide) 2017 | ||
250 | _a 10th Edition, revised | ||
260 |
_a66-68 East Smithfield, London E1W 1AW, UK _b Pharmaceutical Press _c2017 |
||
300 | _a 816 pages | ||
520 | _aAnnotation This is the tenth edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors, compiled by MHRA. Commonly known as the Orange Guide, it remains an essential reference for all manufacturers and distributors of medicines in Europe. It provides a single authoritative source of European and UK guidance, information and legislation relating to the manufacture and distribution of human medicines. The new 2017 edition has been updated to incorporate changes and additions made to the detailed European Community guidelines on Good Manufacturing Practice (GMP) and the revised EU Guidelines on Good Distribution Practice (GDP), including Annexes 15 and 16. | ||
654 | _xDrugs | ||
942 |
_2ddc _cEB |
||
999 |
_c3180 _d3180 |